MX2021005077A - Peptidos y composiciones farmaceuticas para tratar enfermedades oculares. - Google Patents

Peptidos y composiciones farmaceuticas para tratar enfermedades oculares.

Info

Publication number
MX2021005077A
MX2021005077A MX2021005077A MX2021005077A MX2021005077A MX 2021005077 A MX2021005077 A MX 2021005077A MX 2021005077 A MX2021005077 A MX 2021005077A MX 2021005077 A MX2021005077 A MX 2021005077A MX 2021005077 A MX2021005077 A MX 2021005077A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
eye diseases
peptides
treating eye
peptide compounds
Prior art date
Application number
MX2021005077A
Other languages
English (en)
Inventor
Taegon Baik
Jong-Yun Choi
Gyoung-Wook Min
Chun Ho Park
Original Assignee
Yuyu Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma Inc filed Critical Yuyu Pharma Inc
Publication of MX2021005077A publication Critical patent/MX2021005077A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a nuevos péptidos y a composiciones farmacéuticas que los comprenden. Los compuestos peptídicos y las composiciones descritas en la presente son útiles como agentes terapéuticos para tratar enfermedades oculares. Cuando se administran a los ojos, los compuestos peptídicos y las composiciones descritas en la presente aumentan la cantidad de secreción de lágrimas y promueven la recuperación de una córnea dañada.
MX2021005077A 2018-11-14 2019-11-14 Peptidos y composiciones farmaceuticas para tratar enfermedades oculares. MX2021005077A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862767180P 2018-11-14 2018-11-14
PCT/IB2019/001220 WO2020099925A2 (en) 2018-11-14 2019-11-14 Peptides and pharmaceutical compositions for treating eye diseases

Publications (1)

Publication Number Publication Date
MX2021005077A true MX2021005077A (es) 2021-08-11

Family

ID=70732068

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005077A MX2021005077A (es) 2018-11-14 2019-11-14 Peptidos y composiciones farmaceuticas para tratar enfermedades oculares.

Country Status (11)

Country Link
EP (1) EP3880690A4 (es)
JP (1) JP2022507404A (es)
KR (1) KR20210087539A (es)
CN (1) CN113474356A (es)
AU (1) AU2019378162A1 (es)
BR (1) BR112021009341A2 (es)
CA (1) CA3119921A1 (es)
MX (1) MX2021005077A (es)
SG (1) SG11202104178TA (es)
TW (1) TW202031675A (es)
WO (1) WO2020099925A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019024040A2 (pt) * 2017-05-17 2020-09-24 Yuyu Pharma, Inc. peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
KR102662922B1 (ko) * 2022-05-31 2024-05-03 주식회사 세네릭스 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
KR101690539B1 (ko) * 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
EP3441081B1 (en) * 2016-04-08 2020-07-15 Eyebio Korea Collagen type ii alpha-1-based peptide useful for the treatment of an ocular surface disease
KR101795653B1 (ko) * 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR20180074928A (ko) * 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물
BR112019024040A2 (pt) * 2017-05-17 2020-09-24 Yuyu Pharma, Inc. peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo

Also Published As

Publication number Publication date
JP2022507404A (ja) 2022-01-18
WO2020099925A2 (en) 2020-05-22
SG11202104178TA (en) 2021-05-28
EP3880690A4 (en) 2023-09-13
WO2020099925A3 (en) 2020-06-25
TW202031675A (zh) 2020-09-01
BR112021009341A2 (pt) 2021-08-10
CA3119921A1 (en) 2020-05-22
CN113474356A (zh) 2021-10-01
AU2019378162A1 (en) 2021-05-20
EP3880690A2 (en) 2021-09-22
KR20210087539A (ko) 2021-07-12

Similar Documents

Publication Publication Date Title
MX2021005077A (es) Peptidos y composiciones farmaceuticas para tratar enfermedades oculares.
IL272105A (en) Local administration of pharmaceutical agents containing cell-penetrating peptides for use in the treatment of age-related macular degeneration and other eye diseases
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
MX2023003124A (es) Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
MY176514A (en) Compositions and methods for treating ocular edema, neovascularization and related diseases
MX2019008963A (es) Composicion para la prevencion o el tratamiento de deterioros visuales que comprenden acido ursodesoxicolico.
EA201691402A1 (ru) Фармацевтический препарат, содержащий соединение пиридиламиноуксусной кислоты
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
PH12021550039A1 (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
MY178169A (en) Topical ophthalmic peptide formulation
EA202190057A1 (ru) Солюбилизированные апиразы, способы и применение
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
MX2019011925A (es) Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular.
AU2017261303A1 (en) Ophthalmic compositions
MX2022006523A (es) Composicion que comprende budesonida para uso oftalmico.
RU2014106328A (ru) Фармацевтические композиции, содержащие 4-бром-n-(имидазолидин-2-илиден)-1н-бензимидазол-5-амин для лечения заболеваний сетчатки
HK1253191A2 (zh) 含有重組人溶菌酶和重組人表皮生長因子的新型人工淚液
HK1252301A2 (zh) 一種含有重組人溶菌酶的新型人工淚液
EA201690903A1 (ru) Лечение глаукомы с использованием лаквинимода
MX2022009136A (es) Composicion farmaceutica oftalmica y uso de la misma.
MX2018012952A (es) Composicion oftalmica que comprende una combinacion sinergica de glucogeno y acido hialuronico o sal del mismo.
MY184873A (en) Therapeutic agent for sjogren's syndrome dry eye
MX2017012999A (es) Acido pirrolidona carboxilico (pca) para uso oftalmico.
EP3970751C0 (en) OPHTHALMIC COMPOSITION FOR THE TREATMENT OF CORNEAL EDEMA
GR1008511B (el) Οφθαλμικο φαρμακευτικο σκευασμα ελευθερο συντηρητικου περιεχον τραβοπροστη και τιμολολη